BTRC and neoplasm: Moreover, endoplasmic reticulum aminopeptidase 1, a key regulator of innate and adaptive anti-tumor immune responses, was found to interact with USP47 and thus interfered with the interaction of USP47 and β-TrCP, leading to ubiquitination degradation of β-TrCP (Bufalieri et al., 2019).